Literature DB >> 1756238

NGF increases cortical acetylcholine release in rats with lesions of the nucleus basalis.

A J Dekker1, D J Langdon, F H Gage, L J Thal.   

Abstract

Rats received a unilateral lesion of the nucleus basalis by infusion of ibotenic acid. Two weeks after the lesion, osmotic minipumps were implanted, that infused 1 microgram human recombinant nerve growth factor (NGF) or cytochrome-C per day into the lateral ventricle. After four weeks of treatment, release of acetylcholine was measured in the frontal neocortex by means of in-vivo microdialysis. Release was decreased by 75% on the lesioned side; perfusion with 100 mM KCl increased release on the intact side by 130% and on the lesioned side by 80%. Treatment with NGF increased release on the lesioned side twofold, but had no effect on release on the intact side.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756238     DOI: 10.1097/00001756-199110000-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

Review 1.  The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.

Authors:  R Schliebs; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

2.  Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.

Authors:  A J Dekker; L J Thal
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

3.  Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's Disease.

Authors:  Annamaria Morelli; Erica Sarchielli; Giulia Guarnieri; Elisabetta Coppi; Daniela Pantano; Paolo Comeglio; Pamela Nardiello; Anna M Pugliese; Lara Ballerini; Rosanna Matucci; Stefano Ambrosini; Giuseppe Castronovo; Rosa Valente; Benedetta Mazzanti; Sandra Bucciantini; Mario Maggi; Fiorella Casamenti; Pasquale Gallina; Gabriella B Vannelli
Journal:  Front Cell Neurosci       Date:  2017-10-27       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.